Friday, June 14, 2024
wellness India Expo
Home Tags Glargine

Tag: Glargine

Biocon Biologics successfully completes integration of Viatris’ biosimilar business in 31...

In Europe, Biocon Biologics portfolio includes 7 biosimilars: Insulin Aspart and Insulin Glargine, Bevacizumab, Pegfilgrastim, Trastuzumab, Adalimumab, and Etanercept

Biocon’s Insulin, Glargine gets green signal from Japanese regulatory agency

The product is a ready-to-use, prefilled disposable pen with 3 ml of 100IU Insulin Glargine..